Kris has shared her journey with LDN (Low Dose Naltrexone) and MCAS (Mast Cell Activation Syndrome) with us. episode artwork

EPISODE · Sep 11, 2024 · 16 MIN

Kris has shared her journey with LDN (Low Dose Naltrexone) and MCAS (Mast Cell Activation Syndrome) with us.

from The LDN Radio Show About Low Dose Naltrexone

Kris has generously shared her personal journey with LDN, a medication used to treat a variety of conditions including autoimmune diseases, and MCAS, a condition where mast cells release excessive amounts of histamine and other chemicals, causing an array of symptoms such as hives, itching, and digestive problems. In her story, Kris discusses her experiences, including the challenges she faced and the treatments that worked for her. Her story may provide valuable insights and support to others who are also dealing with similar conditions.

Episode metadata supplied by the publisher feed · Published Sep 11, 2024

Embed this episode

NOW PLAYING

Kris has shared her journey with LDN (Low Dose Naltrexone) and MCAS (Mast Cell Activation Syndrome) with us.

0:00 16:07

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The LDN Radio Show About Low Dose Naltrexone?

This episode is 16 minutes long.

When was this The LDN Radio Show About Low Dose Naltrexone episode published?

This episode was published on September 11, 2024.

Can I download this The LDN Radio Show About Low Dose Naltrexone episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!